Skip to content

Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay

Outcomes And Parent Satisfaction Associated With Parent/Nurse Controlled Analgesia In Pediatric Patients With Developmental Delay

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00743730
Acronym
PNCA
Enrollment
94
Registered
2008-08-29
Start date
2005-06-30
Completion date
2010-02-28
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Keywords

developmental delay, cognitive impairment, pain control, post operative pain, opioid, pain assessment, Parent Nurse controlled Analgesic, patient controlled analgesic, children, pain, analgesic, safety, parent satisfaction, nurse satisfaction, Pediatric

Brief summary

The purpose of this study is to compare, the safety, efficacy and level of parent and nurse satisfaction with three methods of opioid administration post-operatively in children (4-18 years of age) with developmental delay.

Detailed description

Children with developmental delay are at higher risk for inadequate pain assessment and management. Patient controlled analgesia (PCA) allows patients to administer opioids by pushing a PCA button when needed. This eliminates the delay of waiting for a nurse to obtain and administer pain medication. PCA has been shown to be safe, effective, and superior to intramuscular, intermittent opioid dosing for pain management in children. Often, children with developmental delays cannot operate a PCA independently, can not self report their pain and are often given pain medication as needed through an IV. Parent/Nurse Controlled Analgesia (PNCA) allows parents and nurses to push the PCA button for patients who are not able to do so themselves. This way of giving pain medicine has not been thoroughly studied. Some healthcare professionals use PNCA for these children, others do not. This study is being done to compare PNCA & intermittent opioid administration. Participants will be randomized into one of the three study groups: 1. Parent/Nurse controlled Analgesia (PNCA) with a continuous intravenous (IV)infusion of pain medicine. 2. PNCA without continuous IV infusion of pain medicine. 3. Pain medicine given through IV administered on an as needed basis(PRN) by the nurse. The Acute Pain Service will follow all three groups of patients throughout the study. This team specializes in the management of children's pain. Pain team is also available 24 hours a day, 7 days a week. The study will continue until child can tolerate pain medication in his/her stomach. Data will be collected regarding safety, efficacy, parent & Nurse satisfaction.

Interventions

OTHERPain and standard side effect management for PNCA with basal method.

Comparing pain management and parent and nurse satisfaction with medication delivery. Standard side effects of nausea, vomiting and pruritis can be expected although not always present. Protocol is in place to treat and manage these side effects. Only PAIN TEAM will be writing analgesic orders and will make medication adjustment per protocol. PCA teaching will be done per Policy and Procedure.

OTHERPain and standard side effect management with PNCA without basal

Comparing pain management and parent nurse satisfaction with pain mediation delivery. Standard side effects of nausea, vomiting and pruritis can be expected although not always present. Protocol is in place to treat and manage these side effects. Only PAIN TEAM will be writing analgesic orders and will make medication adjustment per protocol. PCA teaching will be done per Policy and Procedure.

OTHERPain and standard side effect management with IV on an as needed basis method.

Comparing pain management and parent and nurse satisfaction with pain medication delivery. Standard side effects of nausea, vomiting and pruritis can be expected although not always present. Protocol is in place to treat and manage these side effects. Only PAIN TEAM will be writing analgesic orders and will make medication adjustment per protocol.

Sponsors

Children's Hospital and Health System Foundation, Wisconsin
CollaboratorOTHER
Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children with developmental delay between 4 and 18 years of age who are unable to operate PCA due to developmental delay. * Children scheduled for surgery anticipated to require \>24hour stay with anticipation of IV narcotics will be required. * Children whose parents are able to verbalize an understanding of PNCA. * Parents with fluency in english(both speaking and writing).

Exclusion criteria

* Patients who do not meet inclusion criteria * Patients whose parents do not give informed consent * patients allergic to both morphine and hydromorphone * patients with severe physiologically altering obstructive sleep apnea * Patients who are or are expected to remain on a ventilator * Patients receiving an epidural -

Design outcomes

Primary

MeasureTime frameDescription
Median Pain Score During Shift 1, as Measured With the Face, Legs, Activity, Cry, Consolability ScaleFirst 24 hours on studyPain is measured with the Face, Legs, Activity, Cry, Consolability scale (FLACC) is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The median pain score over the first shift (24 hours) is reported.

Secondary

MeasureTime frameDescription
Number of Patients Requiring Naloxone for Respiratory DepressionDaily, for up to 3 daysNumber of patients requiring naloxone for respiratory depression (our most important side effect)
Parent Satisfaction With the Administration Techniqueparents, once at the end of studyParents were asked Overall, how satisfied were you with the pain relief your child received after surgery? Response options were: 1. Very Dissatisfied, 2. Dissatisfied, 3. Satisfied, 4. Very Satisfied. Responses were scored on a 1-4 scale, with Very Dissatisfied = 1; Dissatisfied = 2; Satisfied = 3; Very Satisfied = 4.

Countries

United States

Participant flow

Participants by arm

ArmCount
I PNCA With Basal
Parent and Nurse Controlled Analgesics with basal Pain and standard side effect management for PNCA with basal method.: Comparing pain management and parent and nurse satisfaction with medication delivery. Standard side effects of nausea, vomiting and pruritis can be expected although not always present. Protocol is in place to treat and manage these side effects. Only PAIN TEAM will be writing analgesic orders and will make medication adjustment per protocol. PCA teaching will be done per Policy and Procedure.
22
II PNCA w/o Basal
Parent and Nurse Controlled Analgesics without basal Pain and standard side effect management with PNCA without basal: Comparing pain management and parent nurse satisfaction with pain mediation delivery. Standard side effects of nausea, vomiting and pruritis can be expected although not always present. Protocol is in place to treat and manage these side effects. Only PAIN TEAM will be writing analgesic orders and will make medication adjustment per protocol. PCA teaching will be done per Policy and Procedure.
30
III PRN Intermittent
Intermittent opioid administered IV on an as needed basis Pain and standard side effect management with IV on an as needed basis method.: Comparing pain management and parent and nurse satisfaction with pain medication delivery. Standard side effects of nausea, vomiting and pruritis can be expected although not always present. Protocol is in place to treat and manage these side effects. Only PAIN TEAM will be writing analgesic orders and will make medication adjustment per protocol.
28
Total80

Baseline characteristics

CharacteristicII PNCA w/o BasalIII PRN IntermittentI PNCA With BasalTotal
Age, Categorical
<=18 years
30 Participants28 Participants22 Participants80 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Age, Continuous12 years12 years10.5 years12 years
Region of Enrollment
United States
30 participants28 participants22 participants80 participants
Sex: Female, Male
Female
15 Participants11 Participants8 Participants34 Participants
Sex: Female, Male
Male
15 Participants17 Participants14 Participants46 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 270 / 340 / 33
serious
Total, serious adverse events
1 / 270 / 340 / 33

Outcome results

Primary

Median Pain Score During Shift 1, as Measured With the Face, Legs, Activity, Cry, Consolability Scale

Pain is measured with the Face, Legs, Activity, Cry, Consolability scale (FLACC) is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The median pain score over the first shift (24 hours) is reported.

Time frame: First 24 hours on study

ArmMeasureValue (MEDIAN)
PNCA With BasalMedian Pain Score During Shift 1, as Measured With the Face, Legs, Activity, Cry, Consolability Scale1.0 units on a scale
PNCA Without BasalMedian Pain Score During Shift 1, as Measured With the Face, Legs, Activity, Cry, Consolability Scale1.8 units on a scale
Intermittent Opioid on as Needed BasisMedian Pain Score During Shift 1, as Measured With the Face, Legs, Activity, Cry, Consolability Scale1.5 units on a scale
Secondary

Number of Patients Requiring Naloxone for Respiratory Depression

Number of patients requiring naloxone for respiratory depression (our most important side effect)

Time frame: Daily, for up to 3 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PNCA With BasalNumber of Patients Requiring Naloxone for Respiratory Depression1 Participants
PNCA Without BasalNumber of Patients Requiring Naloxone for Respiratory Depression0 Participants
Intermittent Opioid on as Needed BasisNumber of Patients Requiring Naloxone for Respiratory Depression0 Participants
Secondary

Parent Satisfaction With the Administration Technique

Parents were asked Overall, how satisfied were you with the pain relief your child received after surgery? Response options were: 1. Very Dissatisfied, 2. Dissatisfied, 3. Satisfied, 4. Very Satisfied. Responses were scored on a 1-4 scale, with Very Dissatisfied = 1; Dissatisfied = 2; Satisfied = 3; Very Satisfied = 4.

Time frame: parents, once at the end of study

Population: Data was obtained from parents who completed the satisfaction survey

ArmMeasureValue (MEAN)Dispersion
PNCA With BasalParent Satisfaction With the Administration Technique1.32 units on a scaleStandard Deviation 0.48
PNCA Without BasalParent Satisfaction With the Administration Technique1.48 units on a scaleStandard Deviation 0.57
Intermittent Opioid on as Needed BasisParent Satisfaction With the Administration Technique1.65 units on a scaleStandard Deviation 0.69

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026